Hypoxia: a window into Mycobacterium tuberculosis latency.
Tuberculosis is a massive public health problem on a global scale and the success of Mycobacterium tuberculosis is linked to its ability to persist within humans for long periods without causing any overt disease symptoms. Hypoxia is predicted to be a key host-induced stress limiting growth of the pathogen in vivo. However, multiple studies in vitro and in vivo indicate that M. tuberculosis adapts to oxygen limitation by entering into a metabolically altered state, while awaiting the opportunity to reactivate. Molecular signatures of bacteria adapted to hypoxia in vitro are accumulating, although correlations to human disease are only now being established. Similarly, defining the mechanisms that control this adaptation is an active area of research. In this review we discuss the historical precedents linking hypoxia and latency, and the gathering knowledge of M. tuberculosis hypoxic responses. We also examine the role of these responses in tuberculosis latency, and identify promising avenues for future studies.
Rustad
Tige R
TR
Seattle Biomedical Research Institute, Seattle, WA, USA.
Sherrid
Ashley M
AM
Minch
Kyle J
KJ
Sherman
David R
DR
D000693:Anaerobiosis; D000818:Animals; D001426:Bacterial Proteins / Q000502:physiology; D004268:DNA-Binding Proteins; D015964:Gene Expression Regulation, Bacterial; D006801:Humans; D000860:Hypoxia / Q000378:metabolism / Q000382:microbiology; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity; D010100:Oxygen / Q000378:metabolism*; D011494:Protein Kinases / Q000502:physiology; D014376:Tuberculosis / Q000378:metabolism / Q000382:microbiology*; D014774:Virulence
D001426:Bacterial Proteins; D004268:DNA-Binding Proteins; C542863:DosR protein, Mycobacterium tuberculosis; D011494:Protein Kinases; D010100:Oxygen